Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-024322

Chief Operating Officer sold 100,000 shares

  • Chief Operating Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kling Douglas F · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Owned after D/I
2025-02-18 Exercise or conversion : show line 1 in the form 10b5-1 +90,782 134,782 D
2025-02-18 Sale : show line 2 in the form 10b5-1 −90,782 44,000 D
2025-02-19 Exercise or conversion : show line 3 in the form 10b5-1 +9,218 53,218 D
2025-02-19 Sale : show line 4 in the form 10b5-1 −9,218 44,000 D
Open-market sales · 100,000 sh

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-18 Exercise or conversion : show line 5 in the form 10b5-1 Option (right to buy) −90,782 135,363 D
2025-02-19 Exercise or conversion : show line 6 in the form 10b5-1 Option (right to buy) −9,218 126,145 D
Loading xslF345X05/ownership.xml…